Anesthesiology and Pain Medicine

Published by: Kowsar

From Pre-Existing Renal Failure to Perioperative Renal Protection: The Anesthesiologist’s Dilemmas

Rudin Domi 1 , * , Gentian Huti 2 , Hektor Sula 1 , Nehat Baftiu 3 , Myzafer Kaci 1 , Artan Bodeci 1 and Albert Pesha 4
Authors Information
1 Department of Anesthesiology and Intensive Care Medicine, “Mother Teresa” University Hospital Center, Faculty of Medicine, Medical University of Albania, Tirana, Albania
2 Department of Anesthesia, American Hospital, Tirana, Albania
3 Clinic of Anesthesiology and Intensive Care, University Clinic Center, Faculty of Medicine, “Hasan Prishtina” University, Prishtine, Kosovo
4 Clinic of Surgery, Regional Hospital, Fier, Albania
Article information
  • Anesthesiology and Pain Medicine: June 2016, 6 (3); e61545
  • Published Online: May 14, 2016
  • Article Type: Review Article
  • Received: August 25, 2015
  • Revised: September 26, 2015
  • Accepted: October 17, 2015
  • DOI: 10.5812/aapm.32386

To Cite: Domi R, Huti G, Sula H, Baftiu N, Kaci M, et al. From Pre-Existing Renal Failure to Perioperative Renal Protection: The Anesthesiologist’s Dilemmas, Anesth Pain Med. 2016 ; 6(3):e61545. doi: 10.5812/aapm.32386.

Abstract
Copyright © 2016, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
3.4. Renal Protection
4. Conclusions
Footnote
References
  • 1. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1)-266[PubMed]
  • 2. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003; 139(2): 137-47[PubMed]
  • 3. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354(23): 2473-83[DOI][PubMed]
  • 4. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative W. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8(4)-12[DOI][PubMed]
  • 5. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2)[DOI][PubMed]
  • 6. Davis JA, May MD, Greenfield BK, Fairey R, Roberts C, Ichikawa G, et al. Contaminant concentrations in sport fish from San Francisco Bay, 1997. Mar Pollut Bull. 2002; 44(10): 1117-29[PubMed]
  • 7. Jones DR, Lee HT. Surgery in the patient with renal dysfunction. Med Clin North Am. 2009; 93(5): 1083-93[DOI][PubMed]
  • 8. Wagener G, Brentjens TE. Anesthetic concerns in patients presenting with renal failure. Anesthesiol Clin. 2010; 28(1): 39-54[DOI][PubMed]
  • 9. Domi R, Ohri I, Andrea G, Sula H, Hafizi A, Janko A, et al. The anesthesiologist s have a role in preventing perioperative renal failure. Anaesth Pain & Intensive Care. 2012; 16: 86-91
  • 10. Kim H, Xu M, Lin Y, Cousins MJ, Eckstein RP, Jordan V, et al. Renal dysfunction associated with the perioperative use of diclofenac. Anesth Analg. 1999; 89(4): 999-1005[PubMed]
  • 11. Myles PS, Power I. Does ketorolac cause postoperative renal failure: how do we assess the evidence? Br J Anaesth. 1998; 80(4): 420-1[PubMed]
  • 12. Brady HBW. 1996; : 1200-52
  • 13. Sawaya BP, Weihprecht H, Campbell WR, Lorenz JN, Webb RC, Briggs JP, et al. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest. 1991; 87(6): 2097-107[DOI][PubMed]
  • 14. Hladunewich M, Rosenthal MH. Pathophysiology and management of renal insufficiency in the perioperative and critically ill patient. Anesthesiol Clin North America. 2000; 18(4): 773-89[PubMed]
  • 15. Hanna J, Nichol A. Acute renal failure and the critically ill. Anaesth Intensive Care Medicine. 13(4): 166-70[DOI]
  • 16. Coleman MD, Shaefi S, Sladen RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol. 2011; 24(1): 70-6[DOI][PubMed]
  • 17. Oltean M, Herlenius G. Renal protection during liver transplantation: an ounce of prevention is worth a pound of cure. Crit Care Med. 2011; 39(6): 1564-5[DOI][PubMed]
  • 18. Jones DR, Thomas Lee H. Perioper renal prot. Best Practice & Research Clinical Anaesthesiology. 22(1): 193-208[DOI][PubMed]
  • 19. Ronco C, Bellomo R. Prevention of acute renal failure in the critically ill. Nephron Clin Pract. 2003; 93(1)-20[PubMed]
  • 20. Lee RW, Di Giantomasso D, May C, Bellomo R. Vasoactive drugs and the kidney. Best Pract Res Clin Anaesthesiol. 2004; 18(1): 53-74[PubMed]
  • 21. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345(19): 1368-77[DOI][PubMed]
  • 22. Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock. 2006; 26(6): 551-7[DOI][PubMed]
  • 23. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012; 367(2): 124-34[DOI][PubMed]
  • 24. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367(20): 1901-11[DOI][PubMed]
  • 25. Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009; 8(6): 669-81[DOI][PubMed]
  • 26. Nagai J, Tanaka H, Nakanishi N, Murakami T, Takano M. Role of megalin in renal handling of aminoglycosides. Am J Physiol Renal Physiol. 2001; 281(2)-44[PubMed]
  • 27. Ranucci M, Ballotta A, Kunkl A, De Benedetti D, Kandil H, Conti D, et al. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol. 2008; 101(8): 1112-8[DOI][PubMed]
  • 28. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol. 2008; 3(5): 1274-81[DOI][PubMed]
  • 29. O'Hara Jr JF. LOW-DOSE “RENAL” DOPAMINE. Anesthesiology Clinics of North America. 2000; 18(4): 835-51[DOI][PubMed]
  • 30. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit care med. 2001; 29(8): 1526-31[PubMed]
  • 31. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002; 28(7): 877-83[DOI][PubMed]
  • 32. Oliver Jr WC, Nuttall GA, Cherry KJ, Decker PA, Bower T, Ereth MH. A comparison of fenoldopam with dopamine and sodium nitroprusside in patients undergoing cross-clamping of the abdominal aorta. Anesth Analg. 2006; 103(4): 833-40[DOI][PubMed]
  • 33. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003; 290(17): 2284-91[DOI][PubMed]
  • 34. Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis. 2007; 49(1): 56-68[DOI][PubMed]
  • 35. Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G, et al. Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med. 2005; 33(11): 2451-6[PubMed]
  • 36. Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, Maglioni E, et al. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. JAMA. 2014; 312(21): 2244-53[DOI][PubMed]
  • 37. Mentzer RM, Oz MC, Sladen RN, Graeve AH, Hebeler RF, Luber JM, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol. 2007; 49(6): 716-26[DOI][PubMed]
  • 38. Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008; 36(1): 81-6[DOI][PubMed]
  • 39. Young EWMD, Diab AMD, Kirsh MMMD. Intravenous Diltiazem and Acute Renal Failure After Cardiac Operations. The Ann of Thorac Surgery. 65(5): 1316-9[DOI]
  • 40. Piper SN, Kumle B, Maleck WH, Kiessling AH, Lehmann A, Rohm KD, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth. 2003; 50(3): 285-92[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments